Mark Ledwidge
7Patents
1h-index
14Co-inventors
40Inventor score
Filing activity: Jul 1, 2011 → Apr 17, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8834858B2 | Treatment for dyslipidemia | Human Necessities | 5 | Active |
| US9670223B2 | Compounds with super-aspirin effects | Human Necessities | 0 | Active |
| US11224614B2 | Compositions and methods for increasing iron intake in a mammal | Human Necessities | 0 | Active |
| US9566342B2 | Compounds for treatment of heart failure | Chemistry; Metallurgy | 0 | Active |
| US11224615B2 | Compositions and methods for increasing iron intake in a mammal | Human Necessities | 0 | Active |
| US11911407B2 | Therapies for cardiomyopathy | Physics | 0 | Active |
| US11179380B2 | Compounds and compositions for use in treating psoriasis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.